SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-18-258924
Filing Date
2018-08-27
Accepted
2018-08-27 16:07:00
Documents
3
Period of Report
2018-09-28

Document Format Files

Seq Description Document Type Size
1 PRE 14A d593315dpre14a.htm PRE 14A 176112
2 GRAPHIC g593315img1.jpg GRAPHIC 186160
3 GRAPHIC g593315img2.jpg GRAPHIC 271438
  Complete submission text file 0001193125-18-258924.txt   807487
Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35670 | Film No.: 181039050
SIC: 2834 Pharmaceutical Preparations